Dr Ravi Misra is a gastroenterologist and endoscopist with a specialist interest in Inflammatory Bowel Disease (IBD). He was appointed as a consultant at St. Mark’s Hospital, London, an internationally recognised centre for the treatment of bowel disease. He is director of the Inflammatory Bowel Disease Unit which is the largest in the country.
He qualified from Imperial College, London in 2005. He completed an intercalated BSc. in Surgical Science. His junior doctor training in medical specialities took place on the Hammersmith hospitals rotation. He entered specialist training on the prestigious North West London rotation. He has completed a fellowship in advanced endoscopy at St Mark’s Hospital and is skilled at diagnostic and therapeutic endoscopy. Dr. Misra runs a complex IBD tertiary service receiving referrals from the south of England.
Dr. Misra is a keen educator. He is the director of postgraduate education at St. Mark’s Hospital. He leads the St. Mark’s postgraduate teaching course which welcomes candidates from all over the world. Dr. Misra is an honorary senior lecturer at Imperial College and teaches on the Imperial Gastroenterology BSc. Course.
Dr. Misra was awarded a PhD from Imperial College through his work with the Centre for Digestive Health to study microbiome changes in IBD. He also has an interest in the impact of diet in newly diagnosed patients with IBD. Dr Misra’s research has provided the opportunity to present his research findings by oral presentation at international conferences and publish articles in peer reviewed journals. Please see google scholar link below.
He was elected onto the European Crohn’s and Colitis Organisation which is the largest society in the world dedicated to treating patients with inflammatory bowel disease. Through his work with the organisation he has published guidelines and taught at international workshops.
He maintains an active research interest as a honorary senior lecturer at Imperial College and supervises students in obtaining higher research degrees. Dr. Misra has contributed to national trials as a principal investigator. He is currently actively recruiting patients to National Institute of Health trials as well as commercial drug trials.
Dr Misra sees all aspects of gastrointestinal disorders; bloating, irritable bowel syndrome, constipation, reflux and abdominal pain. He is proficient at diagnostic and therapeutic endoscopy including the assessment and treatment of inflammatory bowel disease, polyps and cancers. He is proficient at speaking Hindi and Urdu. He employs a patient centred approach with shared decision making. Listening to the patient and understanding their concerns are key to creating an individualised management plan.
